Preaxial polydactyly of the foot: variable expression of trisomy 13 in a case from central Africa by Mbuyi-Musanzayi, Sébastien et al.
Case Report
Preaxial Polydactyly of the Foot: Variable Expression of
Trisomy 13 in a Case from Central Africa
Sébastien Mbuyi-Musanzayi,1,2 Aimé Lumaka,3,4 Bienvenu Yogolelo Asani,2,5
Toni Lubala Kasole,2,6 Prosper Lukusa Tshilobo,3,4 Prosper Kalenga Muenze,2,7
François Tshilombo Katombe,1 and Koenraad Devriendt3
1 Department of Surgery, University Hospital, University of Lubumbashi, P.O. Box 1825, Lubumbashi, Democratic Republic of Congo
2 Center for Human Genetics, Faculty of Medicine, University of Lubumbashi, P.O. Box 1825,
Lubumbashi, Democratic Republic of Congo
3 Center for Human Genetics, University Hospitals, KU Leuven, UZ Leuven, Campus Gasthuisberg, Herestraat 49,
P.O. Box 602, 3000 Leuven, Belgium
4Department of Pediatrics, University Hospitals, University of Kinshasa, P.O. Box 123, Kin XI, Kinshasa, Democratic Republic of Congo
5 Department of Ophthalmology, University Hospital, University of Lubumbashi, P.O. Box 1825,
Lubumbashi, Democratic Republic of Congo
6Department of Pediatrics, University Hospital, University of Lubumbashi, P.O. Box 1825, Lubumbashi, Democratic Republic of Congo
7Department of Gynecology, UniversityHospital, University of Lubumbashi, P.O. Box 1825, Lubumbashi, Democratic Republic of Congo
Correspondence should be addressed to Koenraad Devriendt; koenraad.devriendt@uzleuven.be
Received 6 June 2014; Revised 5 August 2014; Accepted 9 August 2014; Published 1 September 2014
Academic Editor: Philip D. Cotter
Copyright © 2014 Se´bastien Mbuyi-Musanzayi et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Trisomy 13 is a chromosomal disorder characterized by a severe clinical picture of multiple congenital anomalies. We here describe
the clinical and genetic features and prognosis observed in a newborn with trisomy 13 from Central Africa. He presented the rare
feature of preaxial polydactyly of the feet.
1. Introduction
Trisomy 13 (also known as Patau syndrome) is the third most
common autosomal trisomy [1, 2].The prevalence is between
1 : 10,000 and 1 : 20,000 live births [3], but it is estimated that
the frequency of trisomy 13 is 100 times higher in spontaneous
abortions [4, 5]. This chromosomal disorder has a character-
istic phenotype consisting of multiple congenital anomalies
[6], with a classical clinical triad ofmicrophthalmia or anoph-
thalmia, cleft lip and/or palate, and postaxial polydactyly.
However, other anomalies are frequently associated [2, 7].
The objective of this report is to describe the clinical features
and prognosis in a Congolese newborn with trisomy 13 and
to illustrate the occurrence of a rare manifestation in this
syndrome, preaxial polydactyly of the foot.
2. Case Report
The patient, a male, was referred at an age of two days. He
was born at 40 weeks of gestation via a normal spontaneous
vaginal delivery with birth weight 3250 g (−0.5 SD). His
mother was 25 years old and father was 32 years old; both
were healthy and unrelated. Family history was unremark-
able. Prenatal ultrasound was not performed. He presented
median cleft lip and palate, microcephaly (29 cm–−2.6 SD),
bilateral anophthalmia, a posterior scalp defect, short neck,
micropenis, and bilateral cryptorchidism (Figure 1). He had
bilateral postaxial polydactyly of his hands. Of interest, he
also had bilateral preaxial polydactyly of the first toes. The
child was hypotonic and died at age of 5 days from acute
respiratory distress.
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Figure 1: Craniofacial abnormalities observed in the patient. Note (a) median cleft lip and palate, (b) anophthalmia, (c) low-set ears, (d)
aplasia cutis/scalp defect, (e) postaxial polydactyly on the hands, and (f) preaxial polydactyly of the feet.
3. Methods
Genomic DNA was isolated using standard protocols from
the peripheral blood leukocytes and screened for copy
number alterations using the Oxford Gene Technology 8 ×
60 k Array Platform Custom Design (Catalogue number
027216). Array CGH results were interpreted using Oxford
Gene Technology CytoSure Interpret Software v.3.3.2 (OGT
CytoSure, OGT Oxford, UK). All genome coordinates were
according to NCBI human genome build 19 (hg19 Feb 2009).
We performed array-CGH, which revealed trisomy 13: arr
13q12.11-q34 (20,407,270–115,092,581) ×3 or a duplication of
the entire 94.69Mb of chromosome 13. No additional CNVs
were observed. Since karyotyping is not available in this part
of the world, we were not able to exclude a Robertsonian
translocation.
4. Discussion
Wehere present the clinical and genetic data in newbornwith
trisomy 13, diagnosed in the Democratic Republic of Congo.
Since its first description by Patau in 1960 [8], trisomy 13 has
been recognized as one of the three commonly observed auto-
somal trisomies observed in live newborns, worldwide. In
Central Africa, genetics reports on chromosomal imbalances
are scarce, and, to the best of our knowledge, there is only
one earlier report on trisomy 13 in theDemocratic Republic of
Congo, dating from the year 1968 [9].The case we report here
presents the classical triad of cleft lip and palate, postaxial
polydactyly, and anophthalmia. Each of these features is
observed in 60–80% of cases [6, 10].The patient had amedian
cleft lip and palate, with marked hypotelorism, characteristic
of holoprosencephaly, a common finding in trisomy 13. Brain
ultrasound scan could not be performed, since the parents
could not afford to pay for it. In addition, the patients
presented several additional features, commonly observed
in trisomy 13, as shown in Table 1. Postaxial polydactyly
(especially of the hands) is reported in 52–70% of cases
[6, 11–13]. However, the patient presented a very unusual
sign: bilateral preaxial polydactyly of the feet. This finding
has been reported twice before [6, 14]. While this may be a
coincidence, it is tempting to speculate that the expression of
this unusual feature in this Congolese boy may be related to
its different genetic background. However, we have no firm
evidence to support this at present. Postaxial polydactyly,
especially of the hands, is a common feature in Africa, with
a reported incidence between 10.4/1000 births in South and
Central Africa [15, 16] and 22.78/1000 in Nigeria [17]. In
contrast to this, preaxial polydactyly is rare in Central Africa
as elsewhere (Table 1).The early death of the patient presented
here is not unexpected: the median survival of patients with
trisomy 13 varies from 2.5 to 10 days [3, 4, 13, 18]. The
probability of survival until one month of age is about 28%
and only 5–10% survive for one year [1, 3]. The cause of
death may be primary apnea, regardless of the presence of
a CNS abnormality [1, 5, 19]. Also, recurrent apnea may be
related to the common occurrence of a cyanotic heart defect,
pulmonary hypertension, congestive heart failure, aspiration
pneumonia, gastroesophageal reflux, laryngomalacia, and
seizures [20–22]. The case reported here is the first one
with trisomy 13 to be reported in Central Africa (with the
exception of a report in 1968) [9]. This probably reflects the
current lack of teaching and thus interest and knowledge in
human genetics and syndromology [23]. Whereas, in most
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industrialized countries, trisomy 13 is diagnosed prenatally,
the vast majorities of pregnant women in Central Africa
currently do not have access to prenatal ultrasound follow-
up and are thus confronted with serious emotional distress
when facing an unexpected polymalformed newborn. Early
clinical recognition of trisomy 13 at birth remains essential
to optimize guidance for care of the child and his family. For
instance, one can avoid needless and expensive therapeutic or
diagnostic interventions, which is crucial in an environment
where access tomedical care and investigations is difficult and
expensive. Moreover, also in this society, an exact diagnosis
offers the opportunity to discuss the cause, refute commonly
held mystical and traditional beliefs, and relieve misassigned
feelings of guilt [24].
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